Free HTL Guide
Practice

Home › HTL extension › IHC & ISH

HTL extension study guide

IHC & ISH Fundamentals

Understand how preanalytics, target retrieval, reagent specificity, detection chemistry, controls, validation, and interpretation determine whether an immunostain or in situ assay is trustworthy.

PreanalyticsControlsRetrievalDetectionValidation

Start or resume

Learning objectives

1. Preanalytics determine the ceiling

No detection system can fully rescue a target destroyed or altered before staining. Important variables include ischemic time, fixative type, fixation duration, specimen thickness, processing heat, decalcification, section thickness, slide type, drying, unstained-slide age, and storage conditions.

  • Standardize fixation windows for validated clinical or quantitative assays.
  • Use EDTA rather than strong acid when antigen or nucleic-acid preservation is important.
  • Cut consistent sections and use validated charged slides for aggressive retrieval.
  • Protect unstained slides from heat, humidity, light, oxidation, and extended storage.
  • Document deviations before interpreting weak or absent signal as biologic.

2. Control types

ControlQuestion answeredExample
External positive tissueDid the complete assay detect known target?Tonsil, placenta, tumor, cell pellet, or other validated tissue.
Internal positive tissueDid the target stain appropriately within the test specimen?Normal epithelium, vessels, lymphocytes, or stromal cells.
Negative tissueDoes tissue lacking target remain negative?Known target-negative tissue processed similarly.
Reagent negative controlIs signal caused by detection/background rather than the specific primary reagent?Matched negative reagent or validated primary omission, depending on assay.
ISH positive-control probeAre RNA quality and assay steps adequate?Housekeeping-gene probe appropriate for specimen type.
ISH negative-control probeWhat is the nonspecific/background signal?Bacterial or irrelevant-sequence probe validated for the platform.
Control interpretation comes first. A negative test slide is not interpretable when the positive control fails.

3. Target retrieval

ApproachStrengthRisk
Heat-induced epitope retrievalWidely useful for formalin crosslinks; pH and time can be optimized.Excess heat/time can damage morphology, detach tissue, and increase background.
Enzymatic retrievalUseful for selected membrane, extracellular, or heavily crosslinked targets.Overdigestion destroys morphology and may remove target.
Combined or sequential retrievalCan support multiplex or difficult targets.Requires careful order-of-operations validation and tissue integrity controls.

High-pH retrieval is not universally best for nuclear antigens, and low-pH retrieval is not universally best for membrane antigens. Target-specific validation is required.

4. Detection systems

  • Polymer HRP/DAB: common chromogenic system producing brown precipitate; endogenous peroxidase must be controlled.
  • Alkaline phosphatase chromogens: useful alternate colors and selected multiplex sequences; endogenous AP may require blocking.
  • Biotin-based systems: sensitive but can show endogenous-biotin background; polymer systems reduce this concern.
  • Fluorescence: supports multiplexing and quantitative imaging but requires controls for autofluorescence, spectral overlap, exposure, photobleaching, and batch normalization.
  • Tyramide signal amplification: increases sensitivity through localized deposition but can amplify background if specificity and blocking are inadequate.

5. In situ hybridization

ISH localizes DNA or RNA sequences within morphology. Successful assays depend on analyte preservation, probe specificity, permeabilization, stringency, amplification, and control probes.

  • Overfixation and strong-acid decalcification can reduce probe accessibility and nucleic-acid quality.
  • Underfixation or excessive protease can produce tissue loss and diffuse background.
  • Stringency that is too low increases nonspecific binding; too high reduces true signal.
  • Signal must be interpreted in the correct cell type and subcellular compartment.
  • For quantitative assays, define counting rules, positive thresholds, region selection, and exclusion criteria before analysis.

6. Optimization and validation

  1. Define intended use, specimen types, expected localization, and acceptance criteria.
  2. Select representative positive, weak-positive, negative, and challenging material.
  3. Optimize primary reagent/probe concentration, retrieval, incubation, detection, and counterstain systematically.
  4. Assess sensitivity, specificity, precision/reproducibility, carryover, interference, and reportable interpretation as applicable.
  5. Bridge new reagent lots, detection lots, major preanalytic changes, and platform changes.
  6. Document protocol, results, acceptance, training, implementation, and ongoing QC.

7. Troubleshooting patterns

FindingCommon causesDirection
No signal in test and positive controlOmitted reagent, failed detection, wrong retrieval, inactive reagent, instrument failure.Review the complete run before changing specimen interpretation.
Positive control works; test internal control failsSpecimen preanalytics, decalcification, target loss, or tissue-specific inhibition.Review specimen history and assay limitations.
Diffuse backgroundExcess primary, inadequate blocking/washing, dried slide, endogenous enzyme/biotin, overamplification.Optimize one variable at a time with proper controls.
Edge stainingDrying artifact, poor reagent coverage, fixation gradient.Maintain wet coverage and assess specimen fixation.
Tissue liftingInadequate slide adhesion, aggressive retrieval, thick sections, poor drying.Use validated slides and drying/retrieval conditions.
ISH high backgroundInsufficient stringency, excess protease/amplification, dirty reagents, nonspecific probe binding.Review control probes, stringency, digestion, and amplification.

Practice quiz

Best: —
1. Test tissue is negative and the external positive control fails. The test is:
2. Best decalcification approach for IHC and RNA ISH:
3. Excessive heat retrieval may cause:
4. An ISH positive-control probe primarily assesses:
5. HRP/DAB assays commonly require control of:
6. Tyramide amplification requires special attention to:
7. ISH stringency that is too low tends to cause:
8. A new critical antibody lot should be:
9. A normal cell population within the test slide that should stain is:
10. Best optimization strategy:

References and scope

  • ASCP Board of Certification. Current HTL examination content guideline and HT/HTL suggested reading list.
  • Dabbs DJ. Diagnostic Immunohistochemistry: Theranostic and Genomic Applications. 6th ed.
  • Carson FL, Cappellano CH. Histotechnology: A Self-Instructional Text. 5th ed.
  • Use assay-specific IFUs, current validation requirements, local SOPs, and applicable regulatory standards.

Independent educational content. Not affiliated with or endorsed by ASCP or the ASCP Board of Certification.